Carlyle Group Inc.

CIK 0001527166 · WASHINGTON, DC · Quarter end: 2026-06-30 · Filed on: 2026-08-07 · Open the SEC source

Carlyle Group Inc. reported 19 positions worth $10.00B as of June 30, 2026 (13F filed August 7, 2026). Largest holding: MDLN (73.8%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$10.00B
2026 Q2
Positions
19
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
99.9%
Est. Net Flow (Q)
2026 Q2
10 / 19 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1MDLNMedline IncSH$7.38B73.78%187,083,713
2SAROStandardaero IncSH$2.53B25.30%84,587,035
3PHATPhathom Pharmaceuticals IncSH$37.9M0.38%3,496,808
4INVHInvitation Homes IncSH$20.0M0.20%662,900
5PONYPony Ai IncSH$16.4M0.16%2,362,447
6GETYGetty Images Holdings IncSH$5.4M0.05%6,234,252
7SPRBSpruce Biosciences IncSH$2.1M0.02%38,620
8SPWRSunPower IncSH$1.6M0.02%2,343,750
9ACETAdicet Bio IncSH$1.6M0.02%184,295
10FWRDForward Air CorpSH$1.4M0.01%107,214

The free plan shows the top 10 positions. The remaining 9 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Carlyle Group Inc. hold as of Q2 2026?

Carlyle Group Inc. reported 19 positions worth $10.00B in its Q2 2026 13F filing. Largest positions: MDLN (73.8%), SARO (25.3%), PHAT (0.4%), INVH (0.2%) and PONY (0.2%).

What did Carlyle Group Inc. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Carlyle Group Inc. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.